✦ LIBER ✦

Risk management of biosimilars in oncology: each medicine is a work in progress

✍ Scribed by Arnold G. Vulto; Stacy A. Crow

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk management of biosimilars in oncolo

✍ A. G. Vulto 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 French ⚖ 82 KB

Management of early neonatal infections:

✍ The Lancet 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 165 KB

Management of post-liver-transplant bili

✍ Terry L. Jue; Joanne C. Imperial 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Progress in the management of high risk

✍ Heinz, R. ;Hanak, H. ;Stacher, A. 📂 Article 📅 1985 🏛 Springer-Verlag 🌐 English ⚖ 980 KB

What is a manager?, managing people, man

✍ I.H. Hinton 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 292 KB

Opioids in chronic pain management: Is t

✍ Gerald M. Aronoff 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 437 KB